| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Original Studies |
Wallenberg Laboratory, Department of Endocrinology, University of Lund, Malmo 20502, Sweden
Address all correspondence and requests for reprints to: Dr. Xudong Huang, Wallenberg Laboratory, Department of Endocrinology, University of Lund, MAS 46 P 3, Malmo 20502, Sweden. E-mail: xudong.huang{at}endo.mas.lu.se
To examine whether defective muscle glycogen synthase (GYS1) expression is associated with impaired glycogen synthesis in type 2 diabetes and whether the defect is inherited or acquired, we measured GYS1 gene expression and enzyme activity in muscle biopsies taken before and after an insulin clamp in 12 monozygotic twin pairs discordant for type 2 diabetes and in 12 matched control subjects. The effect of insulin on GYS1 fractional activity, when expressed as the increment over the basal values, was significantly impaired in diabetic (15.7 ± 3.3%; P < 0.01), but not in nondiabetic (23.7 ± 1.8%; P = NS) twins compared with that in control subjects (28.1 ± 2.3%). Insulin increased GYS1 messenger ribonucleic acid (mRNA) expression in control subjects (from 0.14 ± 0.02 to 1.74 ± 0.10 relative units; P < 0.01) and in nondiabetic (from 0.24 ± 0.05 to 1.81 ± 0.16 relative units; P < 0.01) and diabetic (from 0.20 ± 0.07 to 1.08 ± 0.14 relative units; P < 0.01) twins. The effect of insulin on GYS1 expression was, however, significantly reduced in the diabetic (P < 0.003), but not in the nondiabetic, twins compared with that in control subjects. The postclamp GYS1 mRNA levels correlated strongly with the hemoglobin A1c levels (r = -0.61; P < 0.001). Despite the decrease in postclamp GYS1 mRNA levels, the GYS1 protein levels were not decreased in the diabetic twins compared with those in the control subjects (2.10 ± 0.46 vs. 2.10 ± 0.34 relative units; P = NS). We conclude that 1) insulin stimulates GYS1 mRNA expression; and 2) impaired stimulation of GYS1 gene expression by insulin in patients with type 2 diabetes is acquired and most likely is secondary to chronic hyperglycemia.
This article has been cited by other articles:
![]() |
P. An, B. I. Freedman, C. L. Hanis, Y.-D. I. Chen, A. B. Weder, N. J. Schork, E. Boerwinkle, M. A. Province, C. A. Hsiung, X. Wu, et al. Genome-wide Linkage Scans for Fasting Glucose, Insulin, and Insulin Resistance in the National Heart, Lung, and Blood Institute Family Blood Pressure Program: Evidence of Linkages to Chromosome 7q36 and 19q13 From Meta-Analysis Diabetes, March 1, 2005; 54(3): 909 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Bouche, S. Serdy, C. R. Kahn, and A. B. Goldfine The Cellular Fate of Glucose and Its Relevance in Type 2 Diabetes Endocr. Rev., October 1, 2004; 25(5): 807 - 830. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Huang, A. Vaag, E. Carlsson, M. Hansson, B. Ahren, and L. Groop Impaired Cathepsin L Gene Expression in Skeletal Muscle Is Associated With Type 2 Diabetes Diabetes, September 1, 2003; 52(9): 2411 - 2418. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maier and A. Olek Diabetes: A Candidate Disease for Efficient DNA Methylation Profiling J. Nutr., August 1, 2002; 132(8): 2440S - 2443. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Huang, A. Vaag, M. Hansson, and L. Groop Down-Regulation of Insulin Receptor Substrates (IRS)-1 and IRS-2 and Src Homologous and Collagen-Like Protein Shc Gene Expression by Insulin in Skeletal Muscle Is Not Associated with Insulin Resistance or Type 2 Diabetes J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 255 - 259. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |